suplatast tosilate has been researched along with Asthma in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (19.51) | 18.2507 |
| 2000's | 25 (60.98) | 29.6817 |
| 2010's | 8 (19.51) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Liu, D; Tan, Y; Zhong, L | 1 |
| Ayyildiz, ZA; Bagriyanik, AH; Karaman, M; Karaman, O; Kiray, M; Tuncel, T; Uysal, P; Uzuner, N; Yilmaz, O | 1 |
| Arisaka, O; Fukuda, H; Fukuda, N; Kanno, N; Ono, M; Tsuchiya, T; Yamada, Y; Yoshihara, S | 1 |
| Li, Y; Liu, D; Tan, YP; Zhong, LL | 1 |
| Abe, M; Fujitaka, K; Fukuhara, K; Hamada, H; Hattori, N; Iwamoto, H; Kohno, N; Masuda, T; Nakashima, T | 1 |
| Abe, T; Arisaka, O; Fukuda, H; Ono, M; Yamada, Y; Yoshihara, S | 1 |
| Kudo, T; Nagata, S; Shimizu, T; Wada, M; Yamashiro, Y | 1 |
| Bae, SJ; Kuwazuka, Y; Lee, JB; Shimizu, K | 1 |
| Arisaka, O; Fukuda, H; Yoshihara, S | 1 |
| Hata, H; Hirose, M; Horiguchi, T; Kondo, R; Miyazaki, J; Otake, Y; Shiga, M; Tachikawa, S | 1 |
| Chida, K; Hashimoto, H; Hayakawa, H; Ide, K; Matsumoto, K; Nakamura, H; Sato, A; Suda, T | 1 |
| Aizawa, H; Fukuyama, S; Hara, N; Inoue, H; Komori, M; Koto, H; Matsumoto, K; Okamoto, M; Yoshida, M | 1 |
| Aoshiba, K; Nagai, A; Nakata, J; Nishimura, K; Takeyama, K; Tamaoki, J | 1 |
| Adachi, M; Matsuo, H; Minoguchi, H; Minoguchi, K; Nakashima, M; Oda, N; Tanaka, A; Tasaki, T; Yokoe, T | 1 |
| Adachi, M; Ogawa, C; Ohta, K; Sano, Y; Suzuki, N; To, Y; Yamada, H | 1 |
| Fujiyama, Y; Miyazaki, H; Murata, T; Yamaga, T | 1 |
| Bando, H; Nakamura, Y; Nii, A; Sano, T; Sone, S; Yanagawa, H; Yoshida, S | 1 |
| Abo, M; Fujimura, M; Ishiura, Y; Myou, S; Nakamura, H; Nobata, K; Oribe, Y | 1 |
| Asada, K; Chida, K; Hashizume, H; Matsuda, H; Suda, T; Suzuki, K; Yokomura, K | 1 |
| Fujita, Y; Hoshino, M; Inoue, T; Miyazawa, T; Nakagawa, T; Saji, J | 1 |
| Corry, DB; Kheradmand, F | 1 |
| Sano, Y; Yamada, H | 1 |
| Adachi, M; Minoguchi, K; Oda, N; Ohta, S; Samson, KT; Tanaka, A; Tazaki, T; Yamamoto, M; Yamamoto, Y; Yokoe, T | 1 |
| Agrawal, DK; Cheng, G; Kim, MJ; Kiniwa, M | 1 |
| Arakawa, M; Fujimori, K; Gejyo, F; Shimatsu, Y; Suzuki, E | 1 |
| Sano, Y | 1 |
| Makino, S; Miyamoto, T; Sano, Y | 1 |
| Arakawa, M; Fujimori, K; Suzuki, E | 1 |
| Iijima, H; Liu, Y; Shirato, K; Tamura, G; Taniguchi, H | 1 |
| Dobashi, K; Horie, T; Iizuka, K; Mori, M; Nagashima, M; Oyama, T; Sato, T; Tsukagoshi, H; Yoshii, A | 1 |
| Hiramatsu, K; Inagaki, N; Nagai, H; Shichijo, M; Shimizu, Y; Takagi, K; Togawa, M | 1 |
| Hamada, H; Hiwada, K; Kohno, N; Sakai, K; Yokoyama, A; Zhao, GD | 1 |
| Kobayashi, Y; Nagata, M; Sakamoto, Y; Yamamoto, H | 1 |
| Payne, D | 1 |
| Aoshiba, K; Isono, K; Kondo, M; Nagai, A; Nakata, J; Sakai, N; Tagaya, E; Tamaoki, J | 1 |
| Aonahata, M; Chida, K; Hashimoto, D; Nakamura, H; Osawa, S; Shirai, T; Suzuki, K | 1 |
| Banno, K; Hanazono, K; Handa, M; Horiguchi, T; Ishibashi, A; Kondo, R; Tachikawa, S | 1 |
| Oshikawa, K; Sugiyama, Y; Yamasawa, H | 1 |
| Agrawal, DK; Suwaki, T; Townley, RG | 1 |
| Ito, N; Ito, T; Kagaya, M; Miura, M; Sano, M; Sasaki, M; Satake, M; Sato, K; Shioya, T; Watanabe, A | 1 |
| Koda, A; Matsuura, N; Yanagihara, Y | 1 |
2 review(s) available for suplatast tosilate and Asthma
| Article | Year |
|---|---|
Breath malodor in an asthmatic patient caused by side-effects of medication: a case report and review of the literature.
Topics: Adult; Anti-Asthmatic Agents; Arylsulfonates; Asthma; Chromatography, Gas; Female; Halitosis; Humans; Sulfides; Sulfonium Compounds | 2003 |
7. Control of allergic airway inflammation through immunomodulation.
Topics: Anti-Allergic Agents; Antibodies; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arylsulfonates; Asthma; Clinical Trials as Topic; Cytokines; Humans; Immunologic Factors; Omalizumab; Sulfonium Compounds; T-Lymphocytes | 2006 |
10 trial(s) available for suplatast tosilate and Asthma
| Article | Year |
|---|---|
Prophylactic effectiveness of suplatast tosilate in children with asthma symptoms in the autumn: a pilot study.
Topics: Adolescent; Anti-Allergic Agents; Arylsulfonates; Asthma; Chemoprevention; Child; Child, Preschool; Disease Progression; Female; Humans; Male; Pilot Projects; Seasons; Sulfonium Compounds; Treatment Outcome | 2014 |
Early intervention with suplatast tosilate for prophylaxis of pediatric atopic asthma: a pilot study.
Topics: Allergens; Animals; Anti-Allergic Agents; Arylsulfonates; Asthma; Chemoprevention; Dermatitis, Atopic; Egg White; Female; Food Hypersensitivity; Humans; Hypersensitivity, Immediate; Incidence; Infant; Ketotifen; Male; Milk; Pilot Projects; Respiratory Sounds; Sulfonium Compounds; Th1 Cells; Th2 Cells; Time Factors; Treatment Outcome | 2009 |
Effect of suplatast tosilate on antileukotriene non-responders with mild-to-moderate persistent asthma.
Topics: Administration, Oral; Adolescent; Anti-Asthmatic Agents; Arylsulfonates; Asthma; Child; Child, Preschool; Female; Humans; Immunologic Factors; Infant; Leukotriene Antagonists; Male; Prospective Studies; Sulfonium Compounds; Treatment Outcome | 2009 |
Long-term monotherapy with suplatast tosilate in patients with mild atopic asthma: a pilot comparison with low-dose inhaled fluticasone.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Androstadienes; Arylsulfonates; Asthma; Disease Progression; Drug Dosage Calculations; Female; Fluticasone; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Respiratory Function Tests; Sulfonium Compounds; Treatment Outcome | 2011 |
Effect of suplatast tosilate on airway hyperresponsiveness and inflammation in asthma patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Allergic Agents; Arylsulfonates; Asthma; Blood Proteins; Bronchial Hyperreactivity; Eosinophil Granule Proteins; Eosinophils; Female; Forced Expiratory Volume; Humans; Inflammation; Japan; Leukocyte Count; Male; Middle Aged; Nitric Oxide; Respiratory Function Tests; Ribonucleases; Sulfonium Compounds; Treatment Outcome; Vital Capacity | 2002 |
Add-on effects of suplatast tosilate in bronchial asthma patients treated with inhaled corticosteroids.
Topics: Administration, Inhalation; Adult; Anti-Asthmatic Agents; Arylsulfonates; Asthma; Beclomethasone; Cytokines; Histamine Antagonists; Humans; Peak Expiratory Flow Rate; Sulfonium Compounds; Th2 Cells | 2003 |
Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma.
Topics: Administration, Oral; Adult; Anti-Allergic Agents; Arylsulfonates; Asthma; Biopsy; Bronchi; Epithelium; Female; Goblet Cells; Humans; Interleukin-3; Interleukin-4; Male; Metaplasia; Middle Aged; Sulfonium Compounds | 2005 |
Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group.
Topics: Administration, Inhalation; Administration, Oral; Anti-Allergic Agents; Anti-Asthmatic Agents; Arylsulfonates; Asthma; Beclomethasone; Circadian Rhythm; Cytokines; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Sulfonium Compounds; Th2 Cells | 2000 |
Effects of suplatast tosilate on airway inflammation and airway hyperresponsiveness.
Topics: Adult; Aged; Anti-Allergic Agents; Arylsulfonates; Asthma; Blood Proteins; Bronchial Hyperreactivity; Eosinophil Granule Proteins; Eosinophilia; Female; Humans; Inflammation; Male; Middle Aged; Peak Expiratory Flow Rate; Ribonucleases; Sputum; Sulfonium Compounds | 2001 |
Effect of suplatast tosilate, a Th2 cytokine inhibitor, on cough variant asthma.
Topics: Adult; Aged; Arylsulfonates; Asthma; Cough; Double-Blind Method; Eosinophils; Female; Histamine Antagonists; Humans; Male; Middle Aged; Sputum; Sulfonium Compounds; Th2 Cells | 2002 |
29 other study(ies) available for suplatast tosilate and Asthma
| Article | Year |
|---|---|
Suplatast tosilate ameliorates airway hyperreactivity and inflammation through inhibition of the GATA‑3/IL‑5 signaling pathway in asthmatic rats.
Topics: Airway Resistance; Animals; Arylsulfonates; Asthma; Bronchial Hyperreactivity; Disease Models, Animal; Eosinophils; GATA3 Transcription Factor; Histamine Antagonists; Inflammation; Interleukin-5; Leukocyte Count; Lung; Male; Ovalbumin; Rats; Signal Transduction; Sulfonium Compounds | 2013 |
The effects of suplatast tosilate treatment and prophylaxis on lung histopathology in a mouse model of chronic asthma.
Topics: Animals; Arylsulfonates; Asthma; Chronic Disease; Disease Models, Animal; Histamine Antagonists; Lung; Male; Mice; Mice, Inbred BALB C; Sulfonium Compounds; Treatment Outcome | 2014 |
[Effects of suplatast tosilate on airway inflammation and interleukin-5 in asthmatic rats].
Topics: Animals; Arylsulfonates; Asthma; Eosinophils; Interleukin-5; Lung; Male; Rats; Rats, Sprague-Dawley; Sulfonium Compounds | 2014 |
Suplatast tosilate protects the lung against hyperoxic lung injury by scavenging hydroxyl radicals.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Arylsulfonates; Asthma; Bleomycin; Bronchoalveolar Lavage Fluid; Chemokine CCL2; Deoxyguanosine; DNA Damage; Humans; Hydroxyl Radical; Interleukin-6; Lipid Peroxidation; Lung; Lung Injury; Mice; Oxidative Stress; Reactive Oxygen Species; Sulfonium Compounds; Th2 Cells | 2017 |
Increase effect of transforming growth factor on eotaxin production by normal cultured dermal fibroblasts stimulated with interleukin-4: inhibitory effect of suplatast tosilate on eotaxin production.
Topics: Anti-Allergic Agents; Arylsulfonates; Asthma; Cells, Cultured; Chemokine CCL11; Chemotactic Factors, Eosinophil; Dose-Response Relationship, Drug; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Gene Expression Regulation; Humans; Interleukin-4; Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin; Sulfonium Compounds; Transforming Growth Factor beta; Up-Regulation | 2010 |
Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
Topics: Adolescent; Anti-Allergic Agents; Arylsulfonates; Asthma; Child; Child, Preschool; Cytokines; Dermatitis, Atopic; Drug Therapy, Combination; Eosinophils; Female; Humans; Immunoglobulin E; Infant; Leukocyte Count; Male; Pharmaceutical Solutions; Retrospective Studies; Sulfonium Compounds; Th1-Th2 Balance; Th2 Cells | 2011 |
Effects of suplatast tosilate on cytokine profile of bronchoalveolar cells in allergic inflammation of the lung.
Topics: Analysis of Variance; Animals; Arylsulfonates; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Histamine Antagonists; Interferon-gamma; Interleukin-4; Interleukin-5; Male; Rats; Rats, Inbred BN; RNA, Messenger; Statistics, Nonparametric; Sulfonium Compounds | 2002 |
A TH2 cytokine inhibitor for airway inflammation in mild asthma.
Topics: Arylsulfonates; Asthma; Bronchial Hyperreactivity; Cytokines; Sulfonium Compounds; Th2 Cells | 2003 |
Suplatast tosilate inhibits thymus- and activation-regulated chemokine production by antigen-specific human Th2 cells.
Topics: Adult; Anti-Allergic Agents; Antigens, Dermatophagoides; Arylsulfonates; Asthma; Cell Line; Chemokines; Dose-Response Relationship, Immunologic; Female; Gene Expression Regulation; Humans; Interferon-gamma; Interleukin-4; Lymphocyte Activation; Male; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonium Compounds; Th1 Cells; Th2 Cells; Thymus Gland; Tuberculin | 2002 |
Effects of suplatast tosilate on allergic eosinophilic airway inflammation in patients with mild asthma.
Topics: Adult; Aged; Anti-Allergic Agents; Arylsulfonates; Asthma; Bronchial Hyperreactivity; Case-Control Studies; Eosinophils; Female; Humans; Inflammation; Male; Middle Aged; Sulfonium Compounds; Th2 Cells | 2003 |
Th2 cytokine inhibition and cough in asthmatic and bronchitic patients.
Topics: Adult; Aged; Anti-Allergic Agents; Arylsulfonates; Asthma; Bronchitis; Capsaicin; Chronic Disease; Cough; Cytokines; Humans; Male; Middle Aged; Sulfonium Compounds; Th2 Cells | 2004 |
Suplatast tosilate alters DC1/DC2 balance in peripheral blood in bronchial asthma.
Topics: Adrenal Cortex Hormones; Aged; Anti-Allergic Agents; Antigen-Presenting Cells; Arylsulfonates; Asthma; Blood Cell Count; Bronchial Hyperreactivity; Dendritic Cells; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Forced Expiratory Volume; Health Services Accessibility; Histamine Antagonists; Humans; Male; Middle Aged; Sulfonium Compounds; Treatment Outcome | 2005 |
Progress in suplatast tosilate research.
Topics: Anti-Allergic Agents; Anti-Asthmatic Agents; Antigens, CD; Arylsulfonates; Asthma; CD4-Positive T-Lymphocytes; Cell Differentiation; Cell Proliferation; Cell Survival; Cytokines; Dendritic Cells; Humans; Lymphocyte Activation; Monocytes; Sulfonium Compounds | 2007 |
Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
Topics: Anti-Allergic Agents; Anti-Asthmatic Agents; Antigens, CD; Arylsulfonates; Asthma; Case-Control Studies; CD4-Positive T-Lymphocytes; Cell Differentiation; Cell Proliferation; Cell Survival; Cells, Cultured; Chemokine CCL17; Chemokines, CC; Coculture Techniques; Dendritic Cells; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferon-gamma; Interleukin-10; Interleukin-12; Interleukin-12 Subunit p40; Interleukin-4; Interleukin-5; Lymphocyte Activation; Monocytes; Sulfonium Compounds | 2007 |
Interaction of suplatast tosilate (IPD) with chloride channels in human blood eosinophils: a potential mechanism underlying its anti-allergic and anti-asthmatic effects.
Topics: Adult; Aged; Anti-Allergic Agents; Anti-Asthmatic Agents; Arylsulfonates; Asthma; Binding Sites; Cell Adhesion; Chemotaxis; Chloride Channels; Chlorides; Endothelial Cells; Eosinophils; Female; Humans; Male; Middle Aged; Respiratory Burst; Respiratory Hypersensitivity; Sulfonium Compounds | 2008 |
[Chronic eosinophilic pneumonia complicated by bronchial asthma and diabetes mellitus successfully treated with suplatast tosilate and high-dose inhaled corticosteroid therapy].
Topics: Administration, Inhalation; Anti-Asthmatic Agents; Arylsulfonates; Asthma; Beclomethasone; Chronic Disease; Diabetes Complications; Diabetes Mellitus; Female; Humans; Interleukin-5; Middle Aged; Pulmonary Eosinophilia; Sulfonium Compounds | 1999 |
[Anti-inflammatory drugs for the treatment of bronchial hyperresponsiveness].
Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Anti-Allergic Agents; Anti-Inflammatory Agents; Arylsulfonates; Asthma; Beclomethasone; Bronchial Hyperreactivity; Female; Humans; Male; Middle Aged; Sulfonium Compounds | 1996 |
Anti-inflammatory effect of suplatast tosilate on mild asthma.
Topics: Adult; Aged; Anti-Allergic Agents; Anti-Inflammatory Agents; Arylsulfonates; Asthma; Bronchial Provocation Tests; Capsules; Cell Movement; Eosinophils; Forced Expiratory Volume; Histamine Antagonists; Humans; Immunoglobulin E; Interleukin-4; Interleukin-5; Middle Aged; Sputum; Sulfonium Compounds | 1997 |
[Cough-variant asthma successfully treated with suplatast tosilate].
Topics: Adult; Anti-Allergic Agents; Arylsulfonates; Asthma; Humans; Male; Sulfonium Compounds | 1998 |
[Antigen-induced airway hyperresponsiveness in infantile guinea pigs].
Topics: Animals; Anti-Allergic Agents; Antigens; Arylsulfonates; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Guinea Pigs; Histamine Antagonists; Leukocyte Count; Male; Ovalbumin; Pyridines; Pyrimidinones; Respiratory Hypersensitivity; Sulfonium Compounds | 1998 |
Kimura's disease associated with bronchial asthma presenting eosinophilia and hyperimmunoglobulinemia E which were attenuated by suplatast tosilate (IPD-1151T).
Topics: Adult; Angiolymphoid Hyperplasia with Eosinophilia; Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Arylsulfonates; Asthma; Biopsy; Blood Proteins; Cytokines; Enzyme-Linked Immunosorbent Assay; Eosinophil Granule Proteins; Eosinophilia; Eosinophils; Follow-Up Studies; Humans; Immunoglobulin E; Job Syndrome; Male; Polymerase Chain Reaction; Ribonucleases; RNA, Messenger; Sulfonium Compounds; T-Lymphocytes, Helper-Inducer | 1998 |
IPD-1151T (suplatast tosilate) inhibits interleukin (IL)-13 release but not IL-4 release from basophils.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Allergic Agents; Arylsulfonates; Asthma; Basophils; Female; Histamine Release; Humans; Interleukin-13; Interleukin-4; Male; Middle Aged; Mites; Sulfonium Compounds | 1999 |
Effect of suplatast tosilate (IPD-1151T) on a mouse model of asthma: inhibition of eosinophilic inflammation and bronchial hyperresponsiveness.
Topics: Animals; Anti-Allergic Agents; Arylsulfonates; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Eosinophilia; Female; Immunoglobulin E; Immunoglobulin G; Lung; Methacholine Chloride; Mice; Ovalbumin; Sulfonium Compounds | 2000 |
[Inhibitory effect of suplatast tosilate on eosinophil migration].
Topics: Anti-Allergic Agents; Arylsulfonates; Asthma; Cell Movement; Eosinophils; Histamine Antagonists; Humans; In Vitro Techniques; Interleukin-6; Platelet Activating Factor; Sulfonium Compounds | 2000 |
High-dose corticosteroids for asthma.
Topics: Adrenal Cortex Hormones; Anti-Allergic Agents; Arylsulfonates; Asthma; Dose-Response Relationship, Drug; Humans; Patient Compliance; Reproducibility of Results; Sulfonium Compounds | 2000 |
Successful treatment of eosinophilic gastroenteritis with suplatast tosilate.
Topics: Anti-Allergic Agents; Anti-Asthmatic Agents; Arylsulfonates; Asthma; Depression, Chemical; Eosinophilia; Gastroenteritis; Humans; Interleukin-4; Interleukin-5; Male; Middle Aged; Secretory Rate; Sulfonium Compounds; Th2 Cells | 2001 |
[Cytokine production by peripheral blood mononuclear cells in bronchial asthma treated with suplatast tosilate].
Topics: Adult; Anti-Allergic Agents; Arylsulfonates; Asthma; Cytokines; Female; Humans; In Vitro Techniques; Interleukin-4; Interleukin-5; Leukocytes, Mononuclear; Male; Middle Aged; Sulfonium Compounds | 2001 |
Modification of eosinophil function by suplatast tosilate (IPD), a novel anti-allergic drug.
Topics: Anti-Allergic Agents; Arylsulfonates; Asthma; Cell Adhesion; Cells, Cultured; Chemotaxis, Leukocyte; Dose-Response Relationship, Drug; Endothelium, Vascular; Eosinophils; Gene Expression Regulation; Humans; Integrin alpha4beta1; Integrins; Interleukin-4; Platelet Activating Factor; Pulmonary Eosinophilia; Receptors, Lymphocyte Homing; Respiratory Hypersensitivity; Sulfonium Compounds; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2001 |
IPD-1151T: a prototype drug for IgE antibody synthesis modulation.
Topics: Animals; Antibodies; Antibody Formation; Arylsulfonates; Asthma; B-Lymphocytes; Dermatitis, Atopic; Female; Hypersensitivity; Immunoglobulin E; Interleukin-4; Mice; Mice, Inbred BALB C; Receptors, Fc; Sulfonium Compounds | 1991 |